Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5NET 1Genitourinary 1Endocrine 1

Conditions

Leukemia, Promyelocytic, Acute 27Leukemia, Myeloid, Acute 27Leukemia 16Myelodysplastic Syndromes 13Multiple Myeloma 9Neuroblastoma 5Melanoma 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Hematologic Neoplasms 4Congenital Abnormalities 4Uterine Cervical Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Thrombocytopenia 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 35Peripheral Blood Stem Cell Transplantation 31dinutuximab 29Radiotherapy 29Granulocyte Colony-Stimulating Factor 29sargramostim 283-Iodobenzylguanidine 27Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16Ifosfamide 15naxitamab 14fludarabine phosphate 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Neuroblastoma × Tretinoin × Clear all
NCT02641782 2022-11-04

NB2013-HR

University of Cologne

Phase 2 Terminated
3 enrolled
CNS

Neuroblastoma

NCT01048086 2016-06-21

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

University of Iowa

Phase 2 Withdrawn
CNSEndocrineNET

Neuroblastoma, Neuroendocrine Tumors

NCT00017225 2013-08-02

Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Neuroblastoma

NCT00533169 2011-12-15

ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
10 enrolled
CNS

Neuroblastoma

NCT00001509 2008-03-04

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled
CNSGenitourinary

Wilms Tumor, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡